Beacon Alert 2025-020 Weekly Regulatory Updates
CMS issued several critical updates this week, ranging from Medicare Drug Price Negotiation submission protocols and civil money penalties to Drug Data Processing System (DDPS) edits and digital infrastructure transitions. This alert is essential reading for compliance, Part D operations, pharmacy data teams, and Medicare Advantage plan sponsors.
Medicare Drug Price Negotiation: Data Submission for 2028 Cycle
CMS has opened the comment period for its Information Collection Request (ICR) related to the 2028 Initial Price Applicability Year under the Medicare Drug Price Negotiation Program.
Key Components:
Small Biotech Exception – Manufacturers may request to exclude a single source drug from negotiation.
Biosimilar Delay – Manufacturers can apply to delay inclusion of biosimilar products.
Renegotiation Eligibility – Voluntary submissions to help CMS evaluate previously selected drugs.
Submission Portal: CMS HPMS and CMS-designated Box folders
Comment Deadline: July 14, 2025
Instructions: CMS HPMS User Access
📌 Impact Area: Compliance
🕒 Action Required By: July 14, 2025
Updated Medicare Prescription Payment Plan Model Documents
CMS seeks feedback on proposed model materials for the Medicare Prescription Payment Plan, reflecting updates required under CMS-4208-F for CY 2026.
Federal Register Identifier: CMS-10882 (OMB 0938-1475)
Supporting docs available via the CMS PRA listing
📩 Comments Due: July 14, 2025
📌 Impact Area: Part D, Finance, Compliance
Revised Civil Money Penalty (CMP) Amounts for 2025
CMS reaffirmed its methodology for calculating CMPs for Medicare Parts C & D.
The revised rule (est. June 2019) includes inflation-adjusted minimum penalty and aggravating factor amounts.
2025 figures are now posted online:
CMS CMP Enforcement Actions
📧 Questions: part_c_part_d_audit@cms.hhs.gov
Medicare Transaction Facilitator (MTF): Operational Documents Released
In preparation for the January 1, 2026 implementation of the Maximum Fair Price (MFP), CMS published finalized materials related to the MTF:
MTF ICR: Final versions now available
User Agreements: Cover Data and Payment Modules (onboarding begins June 2025)
Technical FAQs: Address manufacturer-initiated reversals, credit/debit ledgers, and operational workflows
📌 Impact Area: Part D, Pharmacy, Compliance
🕒 Deadline (MTF ICR): Passed – May 1, 2025
📧 Contact: CMS Drug Price Negotiation Support Teams
DDPS Edits Update – Compounded Insulin Handling
CMS has updated the Drug Data Processing System (DDPS) edits to reflect the Inflation Reduction Act’s insulin pricing provisions:
Effective: May 19, 2025
Key Changes:
Edits 787, 900, 904, 906, 908 updated to reject/bypass compounded insulin products (Compound Code = ‘2’)
Edit 879 now rejects PDEs with Ingredient Cost + Sales Tax ≤ $0.02
📧 Questions: PDE-Operations@cms.hhs.gov
📌 PDEs rejected previously under these criteria can be resubmitted after May 19, 2025
CSSC Operations Website Decommission Notice
CMS announced the decommission of the CSSCOperations.com website effective May 31, 2025.
Resources related to Risk Adjustment and PDE submissions will migrate to CMS.gov
Users are advised to download commonly used files before the cut-off
Help Desk remains available at:
📧 csscoperations@palmettogba.com | ☎ 1-877-534-2772
📌 Impact Area: IT, Compliance, Systems Teams
Medicaid.gov Federal Register Notices – May 2025
CMS submitted five regulatory comment requests for review on May 15–16, 2025. These include updates related to Medicaid funding, deeming authority renewals, health tech ecosystems, and payment policies.
🔗 Visit: FederalRegister.gov Document Search